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Expression of the G-CSF receptor in monocytic
cells is sufficient to mediate hematopoietic
progenitor mobilization by G-CSF in mice
Matthew J. Christopher, Mahil Rao, Fulu Liu, Jill R. Woloszynek,
and Daniel C. Link

Granulocyte colony-stimulating factor (G-CSF), the prototypical mobilizing cytokine, induces
hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow in a cellnonautonomous fashion. This process is mediated, in part, through suppression of osteoblasts
and disruption of CXCR4/CXCL12 signaling. The cellular targets of G-CSF that initiate the
mobilization cascade have not been identified. We use mixed G-CSF receptor (G-CSFR)–
deficient bone marrow chimeras to show that G-CSF–induced mobilization of HSPCs correlates poorly with the number of wild-type neutrophils. We generated transgenic mice in
which expression of the G-CSFR is restricted to cells of the monocytic lineage. G-CSF–
induced HSPC mobilization, osteoblast suppression, and inhibition of CXCL12 expression in
the bone marrow of these transgenic mice are intact, demonstrating that G-CSFR signals in
monocytic cells are sufficient to induce HSPC mobilization. Moreover, G-CSF treatment of
wild-type mice is associated with marked loss of monocytic cells in the bone marrow. Finally,
we show that bone marrow macrophages produce factors that support the growth and/or
survival of osteoblasts in vitro. Together, these data suggest a model in which G-CSFR
signals in bone marrow monocytic cells inhibit the production of trophic factors required for
osteoblast lineage cell maintenance, ultimately leading to HSPC mobilization.
CORRESPONDENCE
Daniel C. Link:
dlink@dom.wustl.edu
Abbreviations used: G-CSFR,
G-CSF receptor; HSPC, hematopoietic stem and progenitor
cell; KLS, c-kit+lineageSca-1+.

In the adult human, the majority of hematopoietic stem and progenitor cells (HSPCs) reside in specialized environments within the
bone marrow collectively referred to as the hematopoietic stem cell niche. The number of
HSPCs in the circulation can be markedly increased in response to several stimuli, including
hematopoietic growth factors, myeloablative
agents, and environmental stresses such as infection. Recently, mobilized stem cells have
become the preferred cellular source for reconstitution of the bone marrow after myeloablative therapy because of their potency,
predictability, and safety. G-CSF, a hematopoietic growth factor, is the most commonly used
mobilizing agent clinically. However, there is
considerable variability in the magnitude of
HSPCs mobilized by G-CSF, and in 10% of
cases, insufficient cells are mobilized for stem
cell transplantation (Anderlini et al., 2001).
An understanding of the mechanisms by which
M.J. Christopher and M. Rao contributed equally to this paper.
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G-CSF elicits mobilization of HSPCs is critical
to the development of novel more effective
mobilizing agents.
There is accumulating evidence that disruption of CXCR4/CXCL12 signaling is a
key step in G-CSF–induced HSPC mobilization. CXCL12 (SDF-1) is a chemokine constitutively expressed at very high levels in the bone
marrow and is a potent chemoattractant for
HSPCs. In mice lacking CXCL12 (Nagasawa
et al., 1996) or its major receptor CXCR4
(Zou et al., 1998), there is a failure of the migration of HSPCs from the fetal liver to the
bone marrow. Moreover, CXCR4/ bone
marrow chimeras exhibit constitutive mobilization and fail to mobilize HSPCs in response
to G-CSF (Ma et al., 1999; Christopher et al.,
2009). G-CSF treatment is associated with
© 2011 Christopher et al. This article is distributed under the terms of an
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first
six months after the publication date (see http://www.rupress.org/terms).
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thus, a role for reduced monocytes in this phenotype is possible. In this study, we used a genetic approach to systematically
examine the contribution of neutrophils and other hematopoietic cell populations to G-CSF–induced HSPC mobilization. We show that G-CSFR expression on monocytic cells in
the bone marrow is sufficient to initiate HSPC mobilization
by G-CSF.
RESULTS
The mobilization response to G-CSF correlates poorly
with the number of wild-type neutrophils
in the bone marrow
To evaluate the importance of neutrophils to G-CSF-induced
mobilization, we generated a series of bone marrow chimeras
by transplanting wild-type and Csf3r/ bone marrow cells in
different ratios into lethally irradiated wild-type mice. Donor
chimerism was assessed in peripheral blood leukocytes 6 wk
after transplantation. As reported previously (Richards et al.,
2003), the contribution of Csf3r/ cells to the B cell lineage
was near that expected based on the input ratio (Fig. S1).
However, because of the marked competitive advantage of
Csf3r+/+ cells to the neutrophil lineage, virtually all of the
neutrophils in the circulation and bone marrow were derived
from Csf3r+/+ cells (Fig. 1, D and E; and not depicted). Moreover, the number of neutrophils in the blood was similar in
all of the chimeras (Fig. S2).
We next assessed the mobilization response to G-CSF in
these chimeras by quantifying CFUs (CFU-C) in the peripheral blood, bone marrow, and spleen. We predicted that an inverse correlation between Csf3r/ donor input and HSPC
mobilization would be observed. Indeed, the number of
CFU-Cs in blood and spleen after treatment with G-CSF was
highest in the 3-to-1 (wild-type-to-Csf3r/) chimeras and
progressively decreased with increasing Csf3r/ donor input
(Fig. 1, A–C). Analysis of donor chimerism in mature neutrophils (Gr-1hi SSChi) in the bone marrow after G-CSF revealed that the great majority of neutrophils were derived
Monocytes mediate G-CSF–induced HSPC mobilization | Christopher et al.
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decreased CXCL12 mRNA and protein expression in the
bone marrow and decreased CXCR4 expression on HSPCs
(Petit et al., 2002; Lévesque et al., 2003a; Semerad et al., 2005;
Christopher et al., 2009). A potential mechanism for the
decreased CXCL12 expression is provided by the observation
that G-CSF treatment is associated with a marked suppression
of osteoblasts (Semerad et al., 2005; Katayama et al., 2006;
Christopher and Link, 2008; Christopher et al., 2009), which
are an important source of CXCL12 in the bone marrow
(Ponomaryov et al., 2000; Semerad et al., 2005; Jung et al.,
2006; Christopher et al., 2009). The importance of the
CXCL12–CXCR4 axis is illustrated by the success of the
CXCR4 inhibitor plerixafor (AMD3100) to rapidly mobilize
HSPCs in humans and mice (Liles et al., 2003; Broxmeyer
et al., 2007).
Through the study of G-CSF receptor (G-CSFR;
Csf3r)/ bone marrow chimeras, we previously showed that
G-CSFR signaling in hematopoietic cells, but not stromal
cells, is required for HSPC mobilization by G-CSF (Liu et al.,
2000).Within the hematopoietic compartment, the G-CSFR
is expressed on neutrophils, monocytes/macrophages, HSPCs,
and a subset of B lymphocytes and NK cells. The simplest
model suggests that G-CSF directly acts upon HSPCs to induce their mobilization. However, strongly arguing against
this model, in mixed bone marrow chimeras containing wildtype and Csf3r/ HSPCs, both types of cells were mobilized
equally after G-CSF treatment (Liu et al., 2000).
There is some evidence implicating neutrophils in G-CSF–
induced HSPC mobilization. During G-CSF treatment,
neutrophils release certain proteases into the bone marrow
microenvironment (Lévesque et al., 2001, 2002, 2003a,b;
Heissig et al., 2002; Petit et al., 2002; Christopherson et al.,
2003). Although controversial, these proteases, through cleavage of CXCL12 (Christopherson et al., 2003; Lévesque et al.,
2003a), c-kit (Lévesque et al., 2003b), and VCAM-1 (Lévesque
et al., 2001), may contribute to HSPC mobilization. A previous study reported that depletion of neutrophils using an
antibody against Gr-1 (Ly6C/G) results in reduced HSPC
mobilization by G-CSF (Pelus et al., 2004). However, Gr-1 is
expressed on both neutrophils and a subset of monocytes;

Figure 1. Neutrophil number in the bone marrow correlates poorly with G-CSF–induced HSPC mobilization.
Wild-type and Csf3r/ bone marrow cells were mixed at the
indicated ratios and transplanted into irradiated recipients.
6 wk later, the mixed bone marrow chimeras were treated
with G-CSF (250 µg/kg/d G-CSF for 7 d), and the number of
CFU-C in the peripheral blood (A), spleen (B), or bone marrow
(C) was measured. As a control, a cohort of mixed chimeras
was analyzed without G-CSF treatment (UnRx). Because
similar results were obtained with each type of chimera, the
untreated data were pooled. The percentage of neutrophils
in the bone marrow derived from wild-type cells (D) and the
absolute number of wild-type neutrophils per femur (E) were
determined after 7 d of G-CSF administration. (F) The number of CFU-C in the blood versus the number of wild-type
neutrophils in bone marrow. The Pearson r2 value is shown.
Data represent the mean ± SEM of six to nine mice and is
pooled from two independent transplantation experiments.
*, P < 0.05 compared with untreated chimeras; +, P < 0.05
compared with 3:1 chimeras.
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Figure 2. G-CSF–induced HSPC mobilization is normal in Rag1/ and NOD/scid/
IL-2null mice. Wild-type, Rag1/ (A), or
NOD/scid/IL-2null mice (B) were treated with
G-CSF (250 µg/kg/d for 5 d) or left untreated.
The number of CFU-C in the blood, bone marrow, and spleen was measured after 5 d of
G-CSF. Data represent the mean ± SEM of
four to five mice per genotype per treatment
group and is pooled from four independent
experiments. *, P < 0.01; **, P < 0.001.

G-CSF–induced HSPC mobilization is normal
in lymphocyte-deficient mice
The contribution of B and T lymphocytes to G-CSF–
induced HSPC mobilization is controversial. Reca et al.
(2007) reported that G-CSF–induced mobilization is impaired in Rag2/, SCID, and Jh mice. In contrast, Katayama
et al. (2006) reported that Rag1/ mice and IL-7R/ mice
exhibited a normal mobilization response to G-CSF. In this
paper, we characterized HSPC mobilization by G-CSF in two
lymphocyte-deficient mouse strains, Rag1/ and NOD/scid/
IL-2null mice. Rag1/ mice lack mature B and T cells, and
NOD/scid/IL-2null mice lack all B, T, and NK cells. Consistent with a previous paper (Katayama et al., 2006), HSPC
mobilization in Rag1/ mice was comparable to that in
wild-type mice (Fig. 2 A). In NOD/scid/IL-2null mice, the
baseline level of circulating HSPC was increased and marked
mobilization in response to G-CSF was observed (Fig. 2 B).
These data demonstrate that B, T, and NK cells are not required for G-CSF–induced mobilization.
Generation of transgenic mice with monocyte-restricted
expression of the G-CSFR
To evaluate the role of monocytes in G-CSF–induced mobilization, we generated transgenic mice in which the CD68
(macrosialin) promoter drives expression of the G-CSFR
(Fig. 3 A). A previous study established that regulatory elements of the CD68 gene are sufficient to direct transgene expression to the monocyte/macrophage lineage (Lang et al.,
2002). Two transgenic founder lines were identified that expressed the GFP in circulating monocytes (unpublished data).
The transgenic founder mice were crossed with Csf3r/
mice to obtain CD68:mGCSFR;Csf3r/ mice, hereafter referred to as CD68:G-CSFR mice. Because the phenotype of
CD68 transgenic mice derived from the two founder lines
was similar, the data have been pooled. It is of note that the
JEM VOL. 208, February 14, 2011

Figure 3. G-CSFR expression is mainly restricted to monocytic
cells in CD68:G-CSFR mice. (A) Schematic of the CD68:G-CSFR transgene. IRES, internal ribosomal entry sequence. (B) Representative histograms showing biotinylated G-CSF binding in the absence (solid line) or
presence (dashed line) of a 100-fold molar excess of unlabeled G-CSF in
the indicated blood leukocyte population. G-CSFR surface expression is
proportional to the difference in median fluorescence intensity (MFI)
between the two curves. (C) The mean MFI in the indicated blood leukocyte population is shown. Data represent the mean ± SEM of four to five
mice per genotype and is pooled from four independent experiments.
253
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from wild-type (Csf3r+/+) cells in all of the chimeras (Fig. 1 D).
In fact, the correlation between the number of wild-type
neutrophils in the bone marrow and CFU-C in the blood
was poor (Fig. 1, E and F).

CD68:G-CSFR mice were generated
from B6CDF1 donor oocytes and
then backcrossed four generations onto
a C57BL/6 background. To minimize
the influence of strain effects on phenotype, littermate controls were used in all studies.

Published January 31, 2011

Table I.

Peripheral blood counts

Parameter
Hemoglobin (g/dL)
Platelets (K/µL)
Leukocytes (K/µL)
Neutrophils (K/µL)
Monocytes (K/µL)
B cells (K/µL)
T cells (K/µL)

Csf3r+/

Csf3r/

CD68:G-CSFR

13.80 ± 1.01
820 ± 147
8.76 ± 1.82
1.38 ± 0.62
0.24 ± 0.12
2.75 ± 0.57
1.95 ± 0.75

15.57 ± 1.06
701 ± 90
8.51 ± 4.10
0.16 ± 0.03
0.12 ± 0.08
3.53 ± 1.52
2.23 ± 0.82

18.00 ± 2.83
678 ± 188
9.82 ± 2.56
0.24 ± 0.05
0.25 ± 0.06
4.92 ± 1.53
1.78 ± 0.42

Csf3r+/ versus Csf3r/ Csf3r+/ versus CD68:G-CSFR
NS
NS
NS
P < 0.001
NS
NS
NS

NS
NS
NS
P < 0.001
NS
P < 0.05
NS

Values represent mean ± SD for two to five mice per genotype and is pooled from three independent experiments. Comparisons in the two right columns were made using a
one-way ANOVA with Bonferroni’s post test corrected for multiple comparisons

blood monocytes with levels similar to that seen in wild-type
or Csf3r+/ mice. G-CSFR expression was barely detectable
on neutrophils, and no expression was detected on B or
T lymphocytes. Similar data were observed using bone marrow cells (unpublished data). These data suggest that hematopoietic expression of the G-CSFR in CD68:G-CSFR mice is
mainly limited to monocytic cells.
CD68:G-CSFR mice are neutropenic
G-CSFR signals on granulocytic precursors are required for
normal cell proliferation and differentiation (Liu et al., 1996).

Figure 4. G-CSF–induced HSPC mobilization is normal in CD68:G-CSFR mice. Mice of the indicated genotype were treated with G-CSF for 7 d or
left untreated. The number of KLS (A) or CFU-C (B) in the blood, bone marrow, and spleen on day 7 is shown. The mRNA expression in the bone marrow
on day 7 of osteocalcin (C) or CXCL12 (D) relative to -actin is shown. Data represent the mean ± SEM of three to five mice per genotype per treatment
group and is pooled from three independent experiments. *, P < 0.01 compared with untreated mice of the same genotype; **, P < 0.05 compared with
untreated mice of the same genotype; †, P < 0.05; ‡, P = 0.07 compared with G-CSF–treated Csf3r+/ mice.
254
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G-CSFR expression in CD68:G-CSFR mice is predicted
to be restricted to cells of the monocyte lineage. To test this
prediction, we measured surface expression of the G-CSFR
on blood leukocytes using a biotinylated G-CSF binding
assay (Liu et al., 1996). Consistent with previous results, in
wild-type and Csf3r+/ mice, expression of the G-CSFR was
highest in neutrophils, detectable but lower in monocytes,
and undetectable in B or T cells (Fig. 3, B and C; and not depicted). As expected, G-CSFR expression was not detected
on any blood leukocytes in Csf3r/ mice. In CD68:G-CSFR
mice, the highest expression of the G-CSFR was detected on

Published January 31, 2011
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Thus, we predicted that the loss of G-CSFR expression
on granulocytic cells in CD68:G-CSFR mice would result
in neutropenia. Indeed, CD68:G-CSFR mice display basal
neutropenia that is similar in magnitude to that seen in
Csf3r/ mice (Table I). Interestingly, CD68:G-CSFR mice
had a modest but significant increase in circulating B lymphocytes. A nonsignificant trend to increased B lymphocytes
also was seen in the Csf3r/ mice (Liu et al., 1996). All other
measured hematopoietic parameters were normal in the
CD68:G-CSFR mice.
G-CSF–induced HSPC mobilization is normal
in CD68:G-CSFR mice
We next evaluated the mobilization response of these mice
to G-CSF. Specifically, we measured the number of c-kit+
lineageSca-1+ (KLS) cells and CFU-C in the blood, bone
marrow, and spleen after 7 d of G-CSF. Consistent with pre
vious results (Liu et al., 1996), in Csf3r+/ mice, G-CSF adminis
tration resulted in a significant increase in KLS cells and
CFU-Cs in the blood and spleen (Fig. 4, A and B). As expected, no mobilization was observed in Csf3r/ mice.
G-CSF treatment of CD68:G-CSFR mice induced HSPC
mobilization that was at least as great as that observed in
control mice. In fact, a significantly greater number of KLS
cells were mobilized to the spleen in CD68:G-CSFR mice.
JEM VOL. 208, February 14, 2011

We have previously shown that G-CSF–induced HSPC
mobilization is associated with osteoblast suppression and decreased CXCL12 expression in the bone marrow (Christopher
et al., 2009). We assessed osteoblast suppression by measuring
mRNA expression of osteocalcin, a specific marker of mature
osteoblasts (Semerad et al., 2005). As reported previously
(Semerad et al., 2005), G-CSF treatment resulted in a significant decrease in osteocalcin and CXCL12 mRNA expression in
the bone marrow of control (Csf3r+/) mice (Figs. 4, C and D).
A similar decrease was observed in CD68:G-CSFR but not
Csf3r/ mice after G-CSF administration. Together, these
data suggest that G-CSFR expression in monocyte lineage
cells is sufficient to induce HSPC mobilization and osteo
blast suppression.
G-CSF treatment of wild-type mice is associated with a loss
of monocytic cells in the bone marrow
To assess the effect of G-CSF on monocytic cells in the
bone marrow, we took advantage of CX3CR1GFP/+ transgenic mice in which monocytic cells express the GFP
(Geissmann et al., 2003). Based on Gr-1 expression, bone mar
row monocytes/macrophages can be divided into two distinct
subsets: Gr-1high GFP+ inflammatory monocytes/macrophages
and Gr-1low GFP+ resident monocytes/macrophages (Fig. 5 A;
Geissmann et al., 2003). CX3CR1GFP/+ mice were treated
255
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Figure 5. G-CSF treatment leads to a loss of monocytic cells from the bone marrow. CX3CR1GFP/+ mice were treated with PBS or G-CSF for 5–7 d
and the flush and bone fractions harvested as described in Materials and methods. (A) Representative dot plot showing the gating strategy used to identify inflammatory (Gr-1high GFP+) and resident monocytes/macrophages (Gr-1low GFP+). (B) The absolute number of inflammatory and resident monocytes/
macrophages in the flushed and bone fractions are shown. Data represent the mean ± SEM of four mice per cohort pooled from two independent experiments. *, P < 0.05; **, P < 0.005; ***, P < 0.001. (C) The percentage of inflammatory and resident monocytes in the flush fraction of bone marrow was
determined at the indicated time points. In these experiments, wild-type mice rather than CX3CR1GFP/+ mice were used, and CD115 was used to identify
monocytic cells. Data represent mean ± SEM of two to six mice per cohort pooled from four independent experiments. **, P < 0.005 compared with untreated mice as determined by one-way ANOVA with Dunnett’s post-test to correct for multiple comparisons.
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with G-CSF for 5 d and the number of inflammatory and
resident monocytes/macrophages in the bone marrow determined by flow cytometry. A recent study suggested that collagenase treatment of murine long bones after flushing of bone
marrow yields a cell population enriched for stromal cells and
stromal macrophages (Crocker and Gordon, 1985; Morikawa
et al., 2009). Thus, in addition to our standard bone marrow
harvesting, we also analyzed cells in the bone fraction obtained after collagenase treatment of flushed femurs. In each
fraction, the number of inflammatory monocytes/macrophages
was significantly reduced (Fig. 5 B). A smaller decrease in
resident monocytes/macrophages in the flushed, but not
bone, fractions was also observed. We next examined the kinetics of monocyte/macrophage loss during G-CSF–induced
mobilization (Fig. 5 C). Because CX3CR1GFP/+ mice were in
limited supply, we performed these experiments using wildtype mice, using CD115 to identify monocytic cells. Importantly, the decrease in the number of inflammatory and
resident monocytes/macrophages in the bone marrow was
maximal by 3 d of G-CSF treatment, a time point at which
osteoblast suppression first becomes evident (Christopher and
Link, 2008).
Macrophages support the growth of osteoblasts in vitro
To further evaluate the role of monocytes/macrophages in
osteoblast growth and survival, we cultured bone marrow
stromal cells in the presence or absence of bone marrow
macrophages. Stromal cells cultured in the presence of macrophages generated many more alkaline phosphatase-positive
(osteoblast lineage) cells than those cultured in the absence of
256

macrophages (Fig. 6 A). Moreover, secretion of osteocalcin
and CXCL12 into the conditioned media was significantly
increased in cultures containing macrophages (Fig. 6, B and C).
It is of note that no alkaline phosphatase colonies or osteocalcin or CXCL12 protein secretion were detected in cultures
of macrophages alone (unpublished data). These data are
consistent with a paper by Chang et al. (2008) showing
that macrophages induced osteoblast mineralization in vitro.
To determine whether macrophages produce a soluble factor
that stimulates osteoblast development, we repeated these experiments, this time including transwell cultures in which the
macrophages were separated from the stromal cells by a semipermeable membrane (Fig. 6 D). Mature osteoblast development, as measured by osteocalcin protein secretion into
conditioned media, was partially induced in the transwell cultures. Collectively, these data suggest that bone marrow macro
phages produce factors, at least some of which are secreted,
that support the growth and/or survival of osteoblasts.
DISCUSSION
The contribution of neutrophils to HSPC mobilization by
G-CSF is controversial. Neutrophils are a major source of
proteases that have been implicated in HSPC mobilization,
including neutrophil elastase, cathepsin G, and MMP-9
(Kjeldsen et al., 1994; Borregaard and Cowland, 1997). However, the importance of these proteases is controversial, as
mice lacking these proteases exhibit a normal mobilization
response to G-CSF (Robinson et al., 2003; Levesque et al.,
2004; Pelus et al., 2004). There is strong evidence showing
that HSPC mobilization by the chemokine IL-8 is dependent
Monocytes mediate G-CSF–induced HSPC mobilization | Christopher et al.
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Figure 6. Macrophages support the growth of mature osteoblasts in vitro. Unfractionated bone marrow cells from wild-type mice were cultured for
10 d and then sorted by flow cytometry into stromal (CD45 Ter119) and macrophage (CD45+ CD115+) cell populations. Stromal cells were cultured for an
additional 14 d in the absence (No Mø) or presence (Mø) of an equal number of macrophages. Ascorbic acid and calcium were included in all cultures to
stimulate mature osteoblast development. (A) Representative photomicrographs of cultures on day 14 that were stained for alkaline phosphatase. (B) Osteo
calcin protein concentration in conditioned media was measured by ELISA at the indicated time points. (C and D) CXCL12 protein (C) and Osteocalcin (D) con
centrations in conditioned media were measured by ELISA on day 14 of culture. Where indicated, the macrophages were separated from the stromal cells
by a semipermeable membrane (transwell). Data represent the mean ± SEM of three independent experiments. *, P < 0.05; **, P < 0.005; ***, P < 0.001.
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In this study, we provide novel evidence that G-CSFR
signaling in monocytic cells is sufficient to induce HSPC
mobilization. We generated transgenic mice in which expression of the G-CSFR is mainly limited to cells of the
monocyte lineage and showed that G-CSF–induced HSPC
mobilization, osteoblast suppression, and decrease in CXCL12
expression are similar to that control mice. In the bone
marrow, there are at least four distinct monocytic cell populations: inflammatory monocytes/macrophages, resident
monocytes/macrophages, myeloid dendritic cells, and osteoclasts. Because the CD68 transgene used in our study is
expected to direct G-CSFR expression in each of these cell
populations, all of them are candidates to mediate HSPC
mobilization. There is considerable (though conflicting) data
on the role of osteoclasts in HSPC mobilization. Kollet et al.
(2006) reported that activation of osteoclasts by injection of
RANKL (RANK ligand) was associated with moderate
HSPC mobilization, and inhibition of osteoclasts, either genetically by knocking out PTP or by injecting mice with
calcitonin, blunts the mobilization response to G-CSF. It is
of note that osteoclasts produce the protease cathepsin K,
which can cleave CXCL12 in vitro (Drake et al., 1996;
Kollet et al., 2006). In contrast, other studies indicate that
osteoclasts may actually inhibit mobilization, as mice that
were given pamidronate, an osteoclast-inhibiting bisphosphonate, exhibit increased mobilization in response to G-CSF
(Takamatsu et al., 1998; Winkler et al., 2010). In contrast to
osteoclasts (Takamatsu et al., 1998; Winkler et al., 2010), we
show that inflammatory and resident monocytes/macrophages
decrease after G-CSF treatment. It is of note that the timing
of the decrease in these cell populations during G-CSF treatment is similar to that reported for the decrease in osteoblasts
(Christopher and Link, 2008) and precedes HSPC mobilization. Definitive identification of the monocytic cell population that mediates G-CSF–induced HSPC mobilization will
require further study.
In summary, we provide evidence that monocytic cells in
the bone marrow are sufficient to elicit HSPC mobilization
and osteoblast suppression by G-CSF. These data suggest a
model in which monocyte lineage cells in the bone marrow
produce trophic factors required for the maintenance of
osteoblasts. G-CSF–induced suppression of monocytic cells
and/or signaling in these cells results in decreased production
of the putative trophic factors, suppression of osteoblast line
age cells (and CXCL12 expression), and ultimately HSPC mobilization. The precise monocytic cell population and factors
produced by these cells that regulate osteoblast lineage cells
are areas of active investigation.
MATERIALS AND METHODS
Mice. Sex- and age-matched wild-type, Csf3r/, and CX3CR1GFP/+
mice on a C57BL/6 background were maintained under SPF conditions
according to methods approved by the Washington University Animal
Studies Committee (Saint Louis, MO). The Csf3r/ mice have been previously
described (Liu et al., 1996). The CX3CR1GFP/+ mice were a gift from
D. Littman (Skirball Institute of Biomolecular Medicine, New York
School of Medicine, New York, NY).
257
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on neutrophils. Csf3r/ mice, which are profoundly neutropenic, fail to mobilize in response to IL-8 (Liu et al., 1997).
Moreover, antibody-mediated depletion of neutrophils (using
anti-CD11a or anti–Gr-1 antibodies) abrogated IL-8–induced
HSPC mobilization (Pruijt et al., 1998, 2002).With respect to
G-CSF, Pelus et al. (2004) reported that neutrophil depletion
using anti–Gr-1 antibodies attenuated G-CSF–induced HSPC
mobilization. However, Gr-1 is expressed on both neutrophils
and a subset of monocytes; thus, a role for reduced monocytes
in this phenotype is possible. In the current study, we demonstrate, using G-CSFR–deficient bone marrow chimeras, that the
mobilization response to G-CSF is poorly correlated with the
number of wild-type neutrophils. Moreover, CD68:G-CSFR
mice, which are neutropenic and have barely detectable expression of G-CSFR on neutrophils, exhibit a normal mobilization
response to G-CSF. These data, although not excluding a role
for neutrophils, strongly suggest that G-CSF signals in neutrophils are not sufficient to induce normal HSPC mobilization.
The contribution of lymphocytes to G-CSF–induced
HSPC mobilization is also controversial. Reca et al. (2007)
reported that G-CSF–induced mobilization is impaired in
Rag2/, SCID, and Jh mice and that this deficit can be
reversed through administration of complement-inducing
immunoglobulin. In contrast, Katayama et al. (2006) reported
that Rag1/ mice and IL-7R/ mice exhibited a normal
mobilization response to G-CSF. Consistent with the latter
findings, we observed that Rag1/ and NOD/scid/IL-2null
mice exhibit a normal mobilization response to G-CSF. The
basis for these discrepancies remains unclear. Although all of
these mouse lines share deficits in B and T lymphopoiesis,
there are subtle differences. For example, natural killer activity is normal in Rag1/ and Rag2/ mice but is absent in
NOD/scid/IL-2null mice. In any case, our data strongly suggest that neither B and T lymphocytes nor NK cells are required for a normal mobilization response to G-CSF.
There is accumulating evidence that monocyte lineage
cells in the bone marrow contribute to osteoblast homeostasis
and HSPC trafficking. Chang et al. (2008) demonstrated that
macrophages are anatomically juxtaposed with endosteal
osteoblasts, forming a canopy over the osteoblasts at sites of
bone formation. Moreover, they showed that ablation of
monocytic cells using the MAFIA transgenic mouse model
resulted in a loss of osteoblasts (Chang et al., 2008). Similarly,
Winkler et al. (2010) recently showed that macrophage ablation using the MAFIA transgenic mouse model or through
administration of clodronate-loaded liposomes resulted in a
loss of osteoblasts and HSPC mobilization. Finally, Chow et al.
demonstrated in a companion paper in this issue that depletion of monocytic lineage cells using a variety of methods is
sufficient to induce mobilization of HSPCs. Together, these
data strongly suggest that monocytic cells produce trophic
factors required for osteoblast maintenance and HSPC retention. Consistent with this conclusion, we show that macrophages support osteoblast growth in vitro, at least in part,
through production of a soluble factor. The identity of these
factors is currently unknown.
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Generation of mixed chimeras. Wild-type (Ly5.1) or Csf3r/ (Ly5.2)
bone marrow cells were harvested. A total of two million bone marrow cells
were mixed at a 3:1, 1:1, 1:3, or 1:9 ratio and injected retroorbitally into lethally irradiated wild-type mice (Ly5.1). Recipient mice were conditioned
with 1,000 cGy from a 137Cesium source at a rate of 95 cGy/min before
transplantation. Prophylactic antibiotics (trimethoprim-sulfamethoxazole;
Alpharma) were given during the initial 2 wk after transplantation. Mice
were analyzed 8–10 wk after transplantation.

Macrophage/osteoblast co-culture. Bone marrow cells were recovered
from the femurs of wild-type mice by flushing with PBS. The femurs were
then infused with PBS containing 50 mg/ml of type II collagenase (Worthington Biochemical) and incubated at 37°C for 30 min. The collagenase-treated
femurs were flushed again with PBS. The cells were pooled (containing both
hematopoietic and stromal cells) and cultured for 7 d in base media (-MEM
with 10% fetal calf serum). On day 7 of culture, cells were trypsinized and
stained with PE-conjugated anti–mouse CD115 and FITC-conjugated anti–
mouse CD45. CD45+ CD115+ (macrophages) and CD45 (stromal cells)
were sorted separately using a MoFlo high-speed cell sorter (Dako). CD45
cells were plated at 10,000 cells per well in a 24-well plate in the absence or
presence of 20,000 CD115+ CD45+ cells. As a control, 20,000 CD115+
CD45+ were plated alone. In each case, after incubation for 1–2 d in base
media, cells were cultured for an additional 14 d in base media supplemented
with 10 mM -glycerophosphate and 50 µg/ml ascorbic acid. Alkaline phosphatase staining was performed on day 14 of culture, per the manufacturer’s
instructions (Vector Laboratories).
G-CSF mobilization protocol. Recombinant human G-CSF (Amgen)
was diluted in phosphate-PBS with 0.1% low endotoxin BSA (SigmaAldrich) and administered at a dose of 250 µg/kg/d either by daily subcutaneous injection for 5 d or by continuous infusion via subcutaneous osmotic
pump for 7 d. Mice were analyzed 3–4 h after the final cytokine dose.
CFU-C assays. Blood, bone marrow, and spleen cells were harvested from mice
using standard techniques, and the number of nucleated cells in these tissues was
quantified using a Hemavet (Drew Scientific) automated cell counter.We plated
10 µl of blood, 5 × 104 nucleated spleen cells, or 2.0 × 104 nucleated bone marrow cells in 2.5 ml methylcellulose media supplemented with a cocktail of
recombinant cytokines (MethoCult 3434; STEMCELL Technologies Inc.).
Cultures were plated in duplicate and placed in a humidified chamber with 5%
CO2 at 37°C. After 7 d of culture, the number of colonies per dish was counted.
The frequency of colonies per femur or spleen was determined based on the
number of cells present in the cell suspension immediately after harvest.
Real-time quantitative RT-PCR. Femurs were flushed with a total of
0.75 ml TRIzol reagent (Invitrogen). RNA was isolated according to the
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Flow cytometry. Red blood cells in peripheral blood and bone marrow
mononuclear cell preparations were lysed in Tris-buffered ammonium chloride buffer, pH 7.2, and incubated with the indicated antibody at 4°C for
1 h in PBS containing 0.1% sodium azide, 1 mM EDTA, and 0.2% (wt/vol)
BSA to block nonspecific binding.The following directly conjugated monoclonal antibodies were used: allophycocyanin–eFluor 780-conjugated rat anti–
mouse Gr-1 (RB6-8C5, IgG2b; eBioscience); allophycocyanin-conjugated
rat anti–mouse CD115 (AFS98, IgG2a; eBioscience); FITC-conjugated rat
anti–mouse Gr-1 (RB6-8C5, IgG2b; eBioscience); allophycocyaninconjugated rat anti–mouse CD3e (17A2, IgG2b; eBioscience); and allophycocyanin–eFluor 780-conjugated rat anti–mouse B220 (RA3-6B2, IgG2a;
eBioscience). For KLS analysis, we used the following antibodies: PE-conjugated
rat anti–mouse Gr-1 (RB6-8C5, IgG2b; eBioscience); PE-conjugated rat
anti–mouse B220 (RA3-6B2, IgG2a; eBioscience); PE-conjugated Armenian
hamster anti–mouse CD3e (145-2C11, IgG; eBioscience); PE-conjugated rat
anti–mouse Ter-119 (TER-119, IgG2b; eBioscience); rat anti–mouse
Sca-1 (D7, IgG2a; eBioscience); and rat anti–mouse c-kit (2B8, IgG2b;
eBioscience). To assess surface G-CSFR expression, G-CSF was biotinylated
using NHS-LC-biotin (Thermo Fisher Scientific) as previously described
(Shimoda et al., 1992). Peripheral blood mononuclear cells were incubated at
4°C for 1 h with biotinylated G-CSF (25 ng/106 cells) in the presence or absence of a 100-fold molar excess of nonlabeled G-CSF, followed by incubation with PE-conjugated streptavidin. All cells were analyzed on a FACScan
flow cytometer.
In some cases, the bone fraction of the bone marrow was analyzed by
flow cytometry. In brief, bone marrow was extracted from femurs either by
flushing with PBS or by centrifugation at 3,300 g for 1 min at room temperature.The pellet was set aside for analysis as the flushed fraction.The flushed femurs were then pulverized with a mortar and pestle, and the bone chips were
incubated with PBS containing 2 mg/ml of type II collagenase (Worthington
Biochemical) at 37°C for 60 min with agitation. After allowing the bone chips
to settle by gravity, the cell suspension was harvested and analyzed.
CXCL12 and osteocalcin ELISAs. For ELISAs, 96-well plates were
coated with 100 µl CXCL12 capture antibody (2 µg/ml) diluted in PBS and
incubated overnight at room temperature. After incubation for 1 h at room
temperature with 300 µl of blocking solution (1% BSA, 5% sucrose,
and 0.05% NaN3), a 100-µl sample was added to each well and incubated for
2 h at room temperature. After washing, 100 µl polyclonal biotinylated
anti–human CXCL12 (250 ng/ml) in ELISA diluent (0.1% BSA, 0.05%
Tween 20 in Tris [tris(hydroxymethyl-)aminomethane)]–buffered saline,
pH 7.3) was added to each well and incubated at room temperature for 2 h.
The reaction was developed by successive incubations with 1 µg/ml horseradish peroxidase streptavidin, substrate solution, and 50 µl 2N H2SO4 to stop
Monocytes mediate G-CSF–induced HSPC mobilization | Christopher et al.

Downloaded from jem.rupress.org on September 13, 2011

Generation of CD68:G-CSFR mouse. To express G-CSF receptor under
the control of the CD68 promoter, we made use of a variant of the CD68
promoter construct described by Lang et al. (2002), in which the 728 bp of
sequence 5 to the ATG and the 83-bp first intron of the human CD68 gene
were subcloned into the pUR19 backbone. A fragment containing bases 93–
2694 of the murine G-CSF receptor cDNA, which includes the entire coding region of the murine G-CSF receptor, was subcloned into this backbone
3 of the first CD68 intron. An IRES-GFP cassette (derived from pIRES2eGFP; Takara Bio Inc.) was subcloned into the backbone 3 of the G-CSF
receptor fragment. For injection into male nuclei of B6CDF1 zygotes, the
construct was digested with DraI and purified according to standard procedures. Offspring derived from the injection were screened by PCR for GFP.
A sample of peripheral blood was taken from those mice positive for GFP by
PCR and analyzed for the presence of GFP+ neutrophils and monocytes.
Transgene-bearing founder mice were mated with C57BL/6 mice with
germline deletion of G-CSF receptor (Csf3r/). Two founder lines produced viable offspring. Initial characterization of these mice revealed similar
mobilization responses to G-CSF, so the data from the two founder lines
were pooled and are collectively referred to as CD68:G-CSFR mice.

manufacturer’s instructions and resuspended in 150 µl RNase/DNase-free
water. Real-time RT-PCR was performed using the TaqMan One-Step RTPCR Master Mix Reagents kit (Applied Biosystems) on a GeneAmp 5700
Sequence Detection System (Applied Biosystems). The reaction mix consisted
of 5 µl RNA, 12.5 µl RT-PCR mix, 200 nM of forward primer, 200 nM of reverse primer, 280 nM of internal probe, and 0.625 µl MultiScribe reverse transcription and RNase inhibitor in a total reaction volume of 25 µl. Reactions
were repeated in the absence of reverse transcription to confirm that DNA
contamination was not present. RNA content was normalized to murine
-actin. PCR conditions were 48°C for 30 min and 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. Primers were:
CXCL12 forward, 5-GAGCCAACGTCAAGCATCTG-3; CXCL12 reverse,
5-CGGGTCAATGCACACTTGTC-3; CXCL12 dT-FAM/TAMRA
probe, 5-TCCAAACTGTGCCCTTCAGATTGTTGC-3; -actin forward, 5-ACCAACTGGGACGATATGGAGAAGA-3; -actin primer,
5-TACGACCAGAGGCATACAGGGACAA-3; -actin dT-FAM/TAMRA
probe, 5-AGCCATGTACGTAGCCATCCAGGCTG-3; osteocalcin forward, 5-TCTCTCTGCTCACTCTGCTGGCC-3; osteocalcin reverse,
5-TTTGTCAGACTCAGGGCCGC-3; and osteocalcin dT-FAM/TAMRA
probe, 5-TGCGCTCTGTCTCTCTGACCTCACAGATGCCA-3.
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the reaction. A microplate reader set at 450 nm was used to determine optical
density with readings at 570 nm subtracted from the results. Recombinant
human CXCL12 was used to generate a standard curve. CXCL12 ELISA
reagents were purchased from R&D Systems. Osteocalcin ELISA was performed using a kit according to the manufacturer’s instructions (Human
Osteocalcin Instant ELISA; eBioscience).
Statistics. Significance was determined using Prism software (GraphPad
Software, Inc.). Statistical significance of differences was calculated using
two-tailed Student’s t tests (assuming equal variance) or, where indicated,
one- or two-way ANOVA with Bonferroni’s or Dunnett’s post testing.
P-values <0.05 were considered significant. All data are presented as mean ±
SEM except as noted.
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